Skip to content
HOME
ABOUT US
What is JLM-BioCity?
What We Do
Board of Advisors
Meet the Team
EVENTS
Past Events
Event Clips
RESOURCES
JLM BIO INNOVATION
JLM COMPANIES
JLM LANDSCAPE
BIOTIPS
BLOG
BRIEFS
JOIN US
Our Partners
Become a Partner
JLM-BIOSYNERGY
CONTACT US
Search for:
Menu
Close
HOME
ABOUT US
What is JLM-BioCity?
What We Do
Board of Advisors
Meet the Team
EVENTS
Past Events
Event Clips
RESOURCES
JLM BIO INNOVATION
JLM COMPANIES
JLM LANDSCAPE
BIOTIPS
BLOG
BRIEFS
JOIN US
Our Partners
Become a Partner
JLM-BIOSYNERGY
CONTACT US
Ayala
Home
>
Ayala Pharmaceuticals Presents Phase 1b Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting for AL101, a Pan-Notch Inhibitor, in Patients with Locally Advanced or Metastatic Solid Tumors
>
Ayala